Literature DB >> 1079768

The two human trypsinogens. Inhibition spectra of the two human trypsins derived from their purified zymogens.

C Figarella, G A Negri, O Guy.   

Abstract

The two human anionic trypsinogens 1 and 2 were purified from human pancreatic juice by gel filtration on Sephadex G-100 and by chromatography on DEAE-cellulose. After activation of their respective zymogens by porcine enterokinase, human trypsins 1 and 2 were studied for their reaction with a wide variety of proteinase inhibitors. Kunitz pancreatic trypsin inhibitor and human pancreatic secretory trypsin inhibitor completely inhibited both human trypsins at a stoichiometric inhibitor-to-enzyme ratio of one to one. In contrast, bovine pancreatic secretory trypsin inhibitor (Kazal's inhibitor) failed to inhibit either human trypsin. The inhibition of both human trypsins by porcine pancreatic secretory trypsin inhibitor was demonstrated. The reactions of the trypsins with chicken ovomucoid, Ascaris lumbricoides (type suis), human sperm and blood plasma trypsin inhibitors were studied. The most striking difference between the two human trypsins was the reaction with soybean trypsin inhibitor (Kunitz). Trypsin 2 was completely inhibited in a one-to-one molar ratio while trypsin 1 was poorly inhibited. The presence of a prekallikrein in human pancreatic juice is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1079768     DOI: 10.1111/j.1432-1033.1975.tb04086.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

Review 1.  Significance for humans of biologically active factors in soybeans and other food legumes.

Authors:  I Liener
Journal:  J Am Oil Chem Soc       Date:  1979-03       Impact factor: 1.849

Review 2.  Trypsin isozymes in the lobster Panulirus argus (Latreille, 1804): from molecules to physiology.

Authors:  Erick Perera; Leandro Rodríguez-Viera; Rolando Perdomo-Morales; Vivian Montero-Alejo; Francisco Javier Moyano; Gonzalo Martínez-Rodríguez; Juan Miguel Mancera
Journal:  J Comp Physiol B       Date:  2014-09-06       Impact factor: 2.200

3.  Elevated serum levels of immunoreactive anionic trypsin (but not cationic trypsin) signals pancreatic disease.

Authors:  A Borgström; A Andrén-Sandberg
Journal:  Int J Pancreatol       Date:  1995-12

4.  Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type-plasminogen-activator N-terminal fragment.

Authors:  D A Fishman; A Kearns; S Larsh; J J Enghild; M S Stack
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

5.  Purification and properties of genetic variants of mouse trypsinogen.

Authors:  T Watanabe
Journal:  Biochem Genet       Date:  1983-08       Impact factor: 1.890

6.  Identification of one- and two-chain forms of trypsinogen 1 produced by a human gastric adenocarcinoma cell line.

Authors:  N Koshikawa; H Yasumitsu; Y Nagashima; M Umeda; K Miyazaki
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

7.  Inhibition of human pancreatic proteinases by mucus proteinase inhibitor, eglin c and aprotinin.

Authors:  D Belorgey; S Dirrig; M Amouric; C Figarella; J G Bieth
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

8.  Identification of a defence mechanism in vivo against the leakage of enterokinase into the blood.

Authors:  D A Grant; A I Magee; D Meeks; C Regan; D R Bainbridge; J Hermon-Taylor
Journal:  Biochem J       Date:  1979-12-15       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.